<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34982039</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>An mHealth App for Fibromyalgia-like Post-COVID-19 Syndrome: Protocol for the Analysis of User Experience and Clinical Data.</ArticleTitle><Pagination><StartPage>e32193</StartPage><MedlinePgn>e32193</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e32193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/32193</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-COVID-19 syndrome, also referred as "long covid," describes persisting symptoms after SARS-CoV-2 infection, including myalgia, fatigue, respiratory, or neurological symptoms. Objective symptoms are often lacking, thus resembling a fibromyalgia-like syndrome. Digital therapeutics have shown efficiency in similar chronic disorders such as fibromyalgia, offering specific disease monitoring and interventions such as cognitive behavioral therapy or physical and respiratory exercise guidance.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This protocol aims to study the requirements and features of a new mobile health (mHealth) app among patients with fibromyalgia-like post-COVID-19 syndrome in a clinical trial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We created a web application prototype for the post-COVID-19 syndrome called "POCOS," as a web-based rehabilitation tool aiming to improve clinical outcomes. Patients without organ damage or ongoing inflammation will be included in the study. App use will be assessed through user experience questionnaires, focus groups, and clinical data analysis. Subsequently, we will analyze cross-sectional and longitudinal clinical data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The developed mHealth app consists of a clinically adapted app interface with a simplified patient-reported outcome assessment, monitoring of medical interventions, and disease activity as well as web-based instructions for specific physical and respiratory exercises, stress reduction, and lifestyle instructions. The enrollment of participants is expected to be carried out in November 2021.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">User experience plays an important role in digital therapeutics and needs to be clinically tested to allow further improvement. We here describe this process for a new app for the treatment of the fibromyalgia-like post-COVID-19 syndrome and discuss the relevance of the potential outcomes such as natural disease course and disease phenotypes.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">PRR1-10.2196/32193.</AbstractText><CopyrightInformation>&#xa9;Marc Blanchard, Lars Backhaus, Pedro Ming Azevedo, Thomas H&#xfc;gle. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 04.02.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blanchard</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4018-9325</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, University Hospital of Lausanne, University of Lausanne, Vaud, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Backhaus</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8566-2569</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, University Hospital of Lausanne, University of Lausanne, Vaud, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ming Azevedo</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3321-266X</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, University Hospital of Lausanne, University of Lausanne, Vaud, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;gle</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3276-9581</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, University Hospital of Lausanne, University of Lausanne, Vaud, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">app</Keyword><Keyword MajorTopicYN="N">application</Keyword><Keyword MajorTopicYN="N">learning</Keyword><Keyword MajorTopicYN="N">long-covid syndrome</Keyword><Keyword MajorTopicYN="N">mHealth</Keyword><Keyword MajorTopicYN="N">mobile health</Keyword><Keyword MajorTopicYN="N">monitoring</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">patient-reported outcome</Keyword><Keyword MajorTopicYN="N">post&#x2013;COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">protocol</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword><Keyword MajorTopicYN="N">reinforcement</Keyword><Keyword MajorTopicYN="N">strategy</Keyword><Keyword MajorTopicYN="N">symptom</Keyword><Keyword MajorTopicYN="N">testing</Keyword><Keyword MajorTopicYN="N">therapy</Keyword><Keyword MajorTopicYN="N">user experience</Keyword><Keyword MajorTopicYN="N">user interface</Keyword></KeywordList><CoiStatement>Conflicts of Interest: MB, LB and TH are shareholders of ATREON Soci&#xe9;t&#xe9; Anonyme.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34982039</ArticleId><ArticleId IdType="pmc">PMC8820761</ArticleId><ArticleId IdType="doi">10.2196/32193</ArticleId><ArticleId IdType="pii">v11i2e32193</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baig A. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021 May;93(5):2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007. 
 
S1871-4021(21)00119-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde Cardona G, Quintana P&#xe1;jaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020 May 15;412:116824. doi: 10.1016/j.jns.2020.116824. 
 
S0022-510X(20)30160-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116824</ArticleId><ArticleId IdType="pmc">PMC7141641</ArticleId><ArticleId IdType="pubmed">32299010</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Jolkkonen J, Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses. Neurosci Biobehav Rev. 2020 Dec;119:184&#x2013;193. doi: 10.1016/j.neubiorev.2020.10.012. 
 
S0149-7634(20)30616-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2020.10.012</ArticleId><ArticleId IdType="pmc">PMC7571477</ArticleId><ArticleId IdType="pubmed">33091416</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M, Schneider J, Br&#xfc;nink S, Greuel S, Lehmann M, Hassan O, Aschman T, Schumann E, Chua RL, Conrad C, Eils R, Stenzel W, Windgassen M, R&#xf6;&#xdf;ler L, Goebel HH, Gelderblom HR, Martin H, Nitsche A, Schulz-Schaeffer WJ, Hakroush S, Winkler MS, Tampe B, Scheibe F, K&#xf6;rtv&#xe9;lyessy P, Reinhold D, Siegmund B, K&#xfc;hl AA, Elezkurtaj S, Horst D, Oesterhelweg L, Tsokos M, Ingold-Heppner B, Stadelmann C, Drosten C, Corman VM, Radbruch H, Heppner FL. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021 Feb;24(2):168&#x2013;175. doi: 10.1038/s41593-020-00758-5.10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S, Lersy F, de S&#xe8;ze J, Ferr&#xe9; JC, Maamar A, Carsin-Nicol B, Collange O, Bonneville F, Adam G, Martin-Blondel G, Rafiq M, Geeraerts T, Delamarre L, Grand S, Krainik A, Caillard S, Constans JM, Metanbou S, Heintz A, Helms J, Schenck M, Lef&#xe8;bvre N, Boutet C, Fabre X, Forestier G, de Beaurepaire I, Bornet G, Lacalm A, Oesterl&#xe9; H, Bolognini F, Messi&#xe9; J, Hmeydia G, Benzakoun J, Oppenheim C, Bapst B, Megdiche I, Henry Feugeas M, Khalil A, Gaudemer A, Jager L, Nesser P, Talla Mba Y, Hemmert C, Feuerstein P, Sebag N, Carr&#xe9; S, Alleg M, Lecocq C, Schmitt E, Anxionnat R, Zhu F, Comby P, Ricolfi F, Thouant P, Desal H, Boulouis G, Berge J, Kaz&#xe9;mi A, Pyatigorskaya N, Lecler A, Saleme S, Edjlali-Goujon M, Kerleroux B, Zorn P, Matthieu M, Baloglu S, Ardellier F, Willaume T, Brisset JC, Boulay C, Mutschler V, Hansmann Y, Mertes P, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, David J, Meyer N, Anheim M, Cotton F. Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study. Radiology. 2020 Nov;297(2):E242&#x2013;E251. doi: 10.1148/radiol.2020202222. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202222</ArticleId><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15(1):145&#x2013;146. doi: 10.1016/j.dsx.2020.12.025. 
 
S1871-4021(20)30520-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Whistler T, Cameron B, Hickie IB, Reeves WC, Lloyd A. Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis. 2006 Jan 31;6:15. doi: 10.1186/1471-2334-6-15. 
 
1471-2334-6-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-6-15</ArticleId><ArticleId IdType="doi">10.1186/1471-2334-6-15</ArticleId><ArticleId IdType="pmc">PMC1373655</ArticleId><ArticleId IdType="pubmed">16448567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayres J, Flint N, Smith E, Tunnicliffe W, Fletcher T, Hammond K, Ward D, Marmion BP. Post-infection fatigue syndrome following Q fever. QJM. 1998 Mar;91(2):105&#x2013;123. doi: 10.1093/qjmed/91.2.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/91.2.105</ArticleId><ArticleId IdType="pubmed">9578893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Ng AW, Lee LS, Kaw G, Kwek SK, Leow MK, Earnest A. Pulmonary function and exercise capacity in survivors of Severe Acute Respiratory Syndrome. Chest. 2004 Oct;126(4):868S. doi: 10.1378/chest.126.4_meetingabstracts.868s-b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.126.4_meetingabstracts.868s-b</ArticleId><ArticleId IdType="pubmed">15358703</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowsett EG, Ramsay AM, McCartney RA, Bell EJ. Myalgic encephalomyelitis--a persistent enteroviral infection? Postgrad Med J. 1990 Jul;66(777):526&#x2013;530. doi: 10.1136/pgmj.66.777.526. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.66.777.526</ArticleId><ArticleId IdType="pmc">PMC2429637</ArticleId><ArticleId IdType="pubmed">2170962</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: Definitions, Similarities, and Differences. Clin Ther. 2019 Apr;41(4):612&#x2013;618. doi: 10.1016/j.clinthera.2018.12.016. 
 
S0149-2918(19)30003-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2018.12.016</ArticleId><ArticleId IdType="pmc">PMC6589349</ArticleId><ArticleId IdType="pubmed">30795933</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front Med (Lausanne) 2020;7:606824. doi: 10.3389/fmed.2020.606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang DH, McCoy RG. Planning for the Post-COVID Syndrome: How Payers Can Mitigate Long-Term Complications of the Pandemic. J Gen Intern Med. 2020 Oct;35(10):3036&#x2013;3039. doi: 10.1007/s11606-020-06042-3. 
 
10.1007/s11606-020-06042-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06042-3</ArticleId><ArticleId IdType="pmc">PMC7375754</ArticleId><ArticleId IdType="pubmed">32700223</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou H. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res. 2021 Aug;52(6):575&#x2013;581. doi: 10.1016/j.arcmed.2021.03.010. 
 
S0188-4409(21)00081-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao C, Liebovitz DM. Consumer Mobile Health Apps: Current State, Barriers, and Future Directions. PM R. 2017 May;9(5S):S106&#x2013;S115. doi: 10.1016/j.pmrj.2017.02.018.S1934-1482(17)30382-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmrj.2017.02.018</ArticleId><ArticleId IdType="pubmed">28527495</ArticleId></ArticleIdList></Reference><Reference><Citation>Peine A, Paffenholz P, Martin L, Dohmen S, Marx G, Loosen SH. Telemedicine in Germany During the COVID-19 Pandemic: Multi-Professional National Survey. J Med Internet Res. 2020 Aug 05;22(8):e19745. doi: 10.2196/19745. 
 
v22i8e19745</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/19745</ArticleId><ArticleId IdType="pmc">PMC7409912</ArticleId><ArticleId IdType="pubmed">32568724</ArticleId></ArticleIdList></Reference><Reference><Citation>Safi S, Danzer G, Schmailzl KJ. Empirical Research on Acceptance of Digital Technologies in Medicine Among Patients and Healthy Users: Questionnaire Study. JMIR Hum Factors. 2019 Dec 29;6(4):e13472. doi: 10.2196/13472. 
 
v6i4e13472</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13472</ArticleId><ArticleId IdType="pmc">PMC6911230</ArticleId><ArticleId IdType="pubmed">31782741</ArticleId></ArticleIdList></Reference><Reference><Citation>Esser M, Boreham A, Ring C, Schreier J. PNS100 The New Reimbursement Route for Digital Health Applications (DIGA) in Germany: Critical Appraisal and First Evaluation of the Possible Effect on the German Healthcare System. Value in Health. 2020 Dec;23:S658&#x2013;S659. doi: 10.1016/j.jval.2020.08.1544. doi: 10.1016/j.jval.2020.08.1544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2020.08.1544</ArticleId><ArticleId IdType="doi">10.1016/j.jval.2020.08.1544</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerke S, Stern AD, Minssen T. Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries. NPJ Digit Med. 2020;3:94. doi: 10.1038/s41746-020-0306-7. doi: 10.1038/s41746-020-0306-7.306</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0306-7</ArticleId><ArticleId IdType="doi">10.1038/s41746-020-0306-7</ArticleId><ArticleId IdType="pmc">PMC7351985</ArticleId><ArticleId IdType="pubmed">32685700</ArticleId></ArticleIdList></Reference><Reference><Citation>John Leon Singh H, Couch D, Yap K. Mobile Health Apps That Help With COVID-19 Management: Scoping Review. JMIR Nurs. 2020;3(1):e20596. doi: 10.2196/20596. 
 
v3i1e20596</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20596</ArticleId><ArticleId IdType="pmc">PMC7467120</ArticleId><ArticleId IdType="pubmed">32897271</ArticleId></ArticleIdList></Reference><Reference><Citation>Macleod M. New Normal: Are virtual doctor?s appointments here to stay? CTV News. 2020. May 14,  [2022-01-31].  
 https://www.ctvnews.ca/health/coronavirus/new-normal-are-virtual-doctor-s-appointments-here-to-stay-1.4939255
.</Citation></Reference><Reference><Citation>Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care. 2020 May;9(5):2207&#x2013;2213. doi: 10.4103/jfmpc.jfmpc_105_20. 
 
JFMPC-9-2207</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_105_20</ArticleId><ArticleId IdType="pmc">PMC7380804</ArticleId><ArticleId IdType="pubmed">32754475</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho C, Lee H. Could Digital Therapeutics be a Game Changer in Psychiatry? Psychiatry Investig. 2019 Mar;16(2):97&#x2013;98. doi: 10.30773/pi.2019.01.20. 
 
pi.2019.01.20</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2019.01.20</ArticleId><ArticleId IdType="pmc">PMC6393746</ArticleId><ArticleId IdType="pubmed">30808114</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi MJ, Kim H, Nah H, Kang D. Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after Stroke. J Stroke. 2019 Oct;21(3):242&#x2013;258. doi: 10.5853/jos.2019.01963. doi: 10.5853/jos.2019.01963.jos.2019.01963</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2019.01963</ArticleId><ArticleId IdType="doi">10.5853/jos.2019.01963</ArticleId><ArticleId IdType="pmc">PMC6780014</ArticleId><ArticleId IdType="pubmed">31587534</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffrey B, Bagala M, Creighton A, Leavey T, Nicholls S, Wood C, Longman J, Barker J, Pit S. Mobile phone applications and their use in the self-management of Type 2 Diabetes Mellitus: a qualitative study among app users and non-app users. Diabetol Metab Syndr. 2019;11:84. doi: 10.1186/s13098-019-0480-4. 
 
480</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-019-0480-4</ArticleId><ArticleId IdType="doi">10.1186/s13098-019-0480-4</ArticleId><ArticleId IdType="pmc">PMC6794726</ArticleId><ArticleId IdType="pubmed">31636719</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Kalun Or C. Acceptance of mHealth by Elderly Adults: A Path Analysis. Proc Hum Factors Ergon Soc Annu Meet. 2021 Feb 09;64(1):755&#x2013;759. doi: 10.1177/1071181320641174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1071181320641174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitkina O, Kim H, Park J. Usability and user experience of medical devices: An overview of the current state, analysis methodologies, and future challenges. Int J Ind Ergon. 2020 Mar;76:102932. doi: 10.1016/j.ergon.2020.102932. doi: 10.1016/j.ergon.2020.102932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ergon.2020.102932</ArticleId><ArticleId IdType="doi">10.1016/j.ergon.2020.102932</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon DH, Rudin RS. Digital health technologies: opportunities and challenges in&#xa0;rheumatology. Nat Rev Rheumatol. 2020 Sep;16(9):525&#x2013;535. doi: 10.1038/s41584-020-0461-x.10.1038/s41584-020-0461-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0461-x</ArticleId><ArticleId IdType="pubmed">32709998</ArticleId></ArticleIdList></Reference><Reference><Citation>Biduski D, Bellei E, Rodriguez J, Zaina L, De Marchi ACB. Assessing long-term user experience on a mobile health application through an in-app embedded conversation-based questionnaire. Comput Hum Behav. 2020 Mar;104:106169. doi: 10.1016/j.chb.2019.106169. doi: 10.1016/j.chb.2019.106169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chb.2019.106169</ArticleId><ArticleId IdType="doi">10.1016/j.chb.2019.106169</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson K, Burford O, Emmerton L. Mobile Health Apps to Facilitate Self-Care: A Qualitative Study of User Experiences. PLoS One. 2016;11(5):e0156164. doi: 10.1371/journal.pone.0156164. 
 
PONE-D-16-02829</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156164</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0156164</ArticleId><ArticleId IdType="pmc">PMC4876999</ArticleId><ArticleId IdType="pubmed">27214203</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Clauw DJ, Fitzcharles M, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010 May;62(5):600&#x2013;610. doi: 10.1002/acr.20140. doi: 10.1002/acr.20140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20140</ArticleId><ArticleId IdType="doi">10.1002/acr.20140</ArticleId><ArticleId IdType="pubmed">20461783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021 Mar;75(3):e13746. doi: 10.1111/ijcp.13746. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, Houben-Wilke S, Burtin C, Posthuma R, Franssen FME, van Loon N, Hajian B, Spies Y, Vijlbrief H, van 't Hul AJ, Janssen DJA, Spruit MA. Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020 Oct;6(4):00542. doi: 10.1183/23120541.00542-2020. 
 
00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden RJ. A Simplified System Usability Scale (SUS) for Cognitively Impaired and Older Adults. Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care. 2020 Sep 16;9(1):180&#x2013;182. doi: 10.1177/2327857920091021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2327857920091021</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumkasian W, Fernandez R, Win K, Petsoglou C, Lord H. Adaptation of the MAUQ and usability evaluation of a mobile phone-based system to promote eye donation. Int J Med Inform. 2021 Jul;151:104462. doi: 10.1016/j.ijmedinf.2021.104462.S1386-5056(21)00088-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2021.104462</ArticleId><ArticleId IdType="pubmed">33933903</ArticleId></ArticleIdList></Reference><Reference><Citation>Haldane V, Koh JJK, Srivastava A, Teo KWQ, Tan YG, Cheng RX, Yap YC, Ong P, Van Dam RM, Foo JM, M&#xfc;ller-Riemenschneider F, Koh GC, Foong PS, Perel P, Legido-Quigley H. User Preferences and Persona Design for an mHealth Intervention to Support Adherence to Cardiovascular Disease Medication in Singapore: A Multi-Method Study. JMIR Mhealth Uhealth. 2019 May 28;7(5):e10465. doi: 10.2196/10465. 
 
v7i5e10465</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10465</ArticleId><ArticleId IdType="pmc">PMC6658252</ArticleId><ArticleId IdType="pubmed">31140445</ArticleId></ArticleIdList></Reference><Reference><Citation>How Great UI Design for Healthcare App Can Help Your Patients. Ego Creative Innovations Limited. 2021. May 18,  [2022-01-31].  
 https://www.ego-cms.com/post/great-healthcare-app-design
.</Citation></Reference><Reference><Citation>Gkatzidou V, Giacomin J, Skrypchuk L. Automotive Human Centred Design Methods. Berlin: De Gruyter; 2021.</Citation></Reference><Reference><Citation>System Usability Scale (SUS) US General Services Administration. Technology Transformation Services.  [2022-01-31].  
 https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html
.</Citation></Reference><Reference><Citation>Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003) 2013;53(2):172&#x2013;181. doi: 10.1331/JAPhA.2013.12202. 
 
S1544-3191(15)30311-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1331/JAPhA.2013.12202</ArticleId><ArticleId IdType="pmc">PMC3919626</ArticleId><ArticleId IdType="pubmed">23571625</ArticleId></ArticleIdList></Reference><Reference><Citation>Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 Jul;37(2):113&#x2013;124. doi: 10.1016/s0738-3991(98)00107-4.S0738-3991(98)00107-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0738-3991(98)00107-4</ArticleId><ArticleId IdType="pubmed">14528539</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine DM, Co Z, Newmark LP, Groisser AR, Holmgren AJ, Haas JS, Bates DW. Design and testing of a mobile health application rating tool. NPJ Digit Med. 2020;3:74. doi: 10.1038/s41746-020-0268-9. doi: 10.1038/s41746-020-0268-9.268</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0268-9</ArticleId><ArticleId IdType="doi">10.1038/s41746-020-0268-9</ArticleId><ArticleId IdType="pmc">PMC7242452</ArticleId><ArticleId IdType="pubmed">32509971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, Ciaffi J, Mancarella L, Lisi L, Brusi V, Cavallari C, D'Onghia M, Mari A, Borlandelli E, Faranda Cordella J, La Regina M, Viola P, Ruscitti P, Miceli M, De Giorgio R, Baldini N, Borghi C, Gasbarrini A, Iagnocco A, Giacomelli R, Faldini C, Landini MP, Meliconi R. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021 Aug;7(3):e001735. doi: 10.1136/rmdopen-2021-001735. 
 
rmdopen-2021-001735</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001735</ArticleId><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020 Oct;125(4):436&#x2013;440. doi: 10.1016/j.bja.2020.05.021. 
 
S0007-0912(20)30403-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.021</ArticleId><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, G&#xf3;es-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021 Apr 18;13(4):700. doi: 10.3390/v13040700. 
 
v13040700</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>